United States:
FDA Announces Classification Of Internal Tissue Marker
To print this article, all you need is to be registered or login on Mondaq.com.
In the August 5, 2015, Federal Register, FDA
announced the classification of the Internal Tissue Marker into
class II (special controls). Various testing measures and labeling
will be required to mitigate the identified risks of adverse tissue
reaction, ineffective marking, and improper use.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
